DEA schedule
Is Nexletol a controlled substance?
Nexletol contains bempedoic acid. Federal schedule from the FDA NDC directory, checked against the DEA controlled substances list.
Source: FDA NDC Directory file dated 2026-10-22. Publisher page
No. Nexletol (bempedoic acid) is not a federally controlled substance. None of its FDA NDC listings carries a DEA schedule, and bempedoic acid is not on the DEA controlled substances list.
Run it in Rivvi
Which 2027 plans near you dropped or restricted Nexletol?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Schedule check
| Source | What it lists |
|---|---|
| FDA NDC directory | 1 prescription listings from 1 labelers, none with a DEA schedule |
| DEA controlled substances list | bempedoic acid is not on the list |
Nexletol NDC listings
| NDC | Product | Form | Strength | Labeler | DEA schedule |
|---|---|---|---|---|---|
| 72426-118 | Nexletol | tablet, film coated | 180 mg/1 | Esperion Therapeutics, Inc. | None |
Questions
Is Nexletol a controlled substance?
No. Nexletol (bempedoic acid) is not a federally controlled substance. None of its FDA NDC listings carries a DEA schedule, and bempedoic acid is not on the DEA controlled substances list.
Is Nexletol a narcotic?
No. Nexletol (bempedoic acid) is not on the DEA controlled substances list, so the DEA does not classify it as a narcotic. Its FDA established pharmacologic class is Adenosine Triphosphate-Citrate Lyase Inhibitor.
Does this page cover state schedules?
No. This page reports the federal schedule only. Some states schedule drugs on their own; check your state board of pharmacy.